Evidence map›Paper›PMID 23607659›Full record

ArticleClinical and experimental immunology2013

Exposure to anthrax toxin alters human leucocyte expression of anthrax toxin receptor 1.

R J Ingram, A Harris, S Ascough, G Metan, M Doganay, L Ballie, E D Williamson, H Dyson, J H Robinson, S Sriskandan and 1 more

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Clinical and experimental immunology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. One Health Assessment ofMicroorganisms · 2023
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

R J IngramSection of Infectious Diseases and Immunity, Department of Medicine Imperial College, Hammersmith Hospital, London.
A Harris
S Ascough
G Metan
M Doganay
L Ballie
E D Williamson
H Dyson
J H Robinson
S Sriskandan
D M Altmann
Hammersmith Hospital · GBDefence Science and Technology Laboratory · GBErciyes University · TRCardiff University · GBNewcastle University · GBQueen's University Belfast · GB

Funding

Medical Research Council G0800777
6 · The paper itself

Abstract

Anthrax is a toxin-mediated disease, the lethal effects of which are initiated by the binding of protective antigen (PA) with one of three reported cell surface toxin receptors (ANTXR). Receptor binding has been shown to influence host susceptibility to the toxins. Despite this crucial role for ANTXR in the outcome of disease, and the reported immunomodulatory consequence of the anthrax toxins during infection, little is known about ANTXR expression on human leucocytes. We characterized the expression levels of ANTXR1 (TEM8) on human leucocytes using flow cytometry. In order to assess the effect of prior toxin exposure on ANTXR1 expression levels, leucocytes from individuals with no known exposure, those exposed to toxin through vaccination and convalescent individuals were analysed. Donors could be defined as either 'low' or 'high' expressers based on the percentage of ANTXR1-positive monocytes detected. Previous exposure to toxins appears to modulate ANTXR1 expression, exposure through active infection being associated with lower receptor expression. A significant correlation between low receptor expression and high anthrax toxin-specific interferon (IFN)-γ responses was observed in previously infected individuals. We propose that there is an attenuation of ANTXR1 expression post-infection which may be a protective mechanism that has evolved to prevent reinfection.

Indexed as

AnthraxAnthrax VaccinesAntigens, BacterialBacterial ToxinsCohort StudiesConvalescenceFlow CytometryGene Expression RegulationHumansImmunization, SecondaryInterferon-gammaLeukocytes, MononuclearMicrofilament ProteinsNeoplasm ProteinsReceptors, Cell SurfaceSkin Diseases, Bacterialanthrax toxinAnthrax VaccinesAntigens, BacterialANTXR1 protein, humanBacterial ToxinsInterferon-gammaMicrofilament ProteinsNeoplasm ProteinsReceptors, Cell Surface

Identifiers

PMID23607659
PMCPMC3694538
OpenAlexW1799640410

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.